(0.15%) 5 530.00 points
(0.19%) 39 545 points
(0.09%) 19 946 points
(0.29%) $81.78
(-1.31%) $2.57
(-0.02%) $2 339.20
(-0.25%) $29.49
(-0.65%) $995.40
(-0.35%) $0.930
(-0.39%) $10.63
(-0.17%) $0.789
(1.95%) $87.40
5.24% $ 0.450
Live Chart Being Loaded With Signals
Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid therapies for patients with acute and chronic pain...
Stats | |
---|---|
Dzisiejszy wolumen | 93 590 |
Średni wolumen | 0 |
Kapitalizacja rynkowa | 320.69M |
EPS | $-0.240 ( Q1 | 2024-05-13 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 61.14 |
ATR14 | $0.0210 (4.67%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-10-04 | Ji Henry | Buy | 200 000 | Nonstatutory Stock Option (right to buy) |
2023-10-04 | Shah Jaisim | Buy | 200 000 | Nonstatutory Stock Option (right to buy) |
2023-10-04 | Wu Yue Alexander | Buy | 250 000 | Nonstatutory Stock Option (right to buy) |
2023-10-04 | Chun Jay | Buy | 250 000 | Nonstatutory Stock Option (right to buy) |
2023-10-04 | Ma Stephen Hoi | Buy | 150 000 | Nonstatutory Stock Option (right to buy) |
INSIDER POWER |
---|
-88.45 |
Last 30 transactions |
Buy: 13 352 730 | Sell: 150 694 281 |
Wolumen Korelacja
Scilex Holding Company Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Scilex Holding Company Korelacja - Waluta/Towar
Scilex Holding Company Finanse
Annual | 2023 |
Przychody: | $46.74M |
Zysk brutto: | $26.92M (57.58 %) |
EPS: | $-0.880 |
FY | 2023 |
Przychody: | $46.74M |
Zysk brutto: | $26.92M (57.58 %) |
EPS: | $-0.880 |
FY | 2022 |
Przychody: | $38.03M |
Zysk brutto: | $27.24M (71.61 %) |
EPS: | $-0.170 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Scilex Holding Company
Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid therapies for patients with acute and chronic pain. The company\'s principal product includes ZTlido 1.8%, a prescription lidocaine topical product for the relief of neuropathic pain related with post-herpetic neuralgia, which is a form of post-shingles nerve pain. It also offers SP-102 or SEMDEXA, a viscous gel formulation of corticosteroid for epidural injections that is in a Phase 3 clinical trial to treat lumbosacral radicular pain; SP-103 for the treatment of low back pain, which is in Phase 2 clinical trails; and SP-104, a novel low-dose delayed-release naltrexone hydrochloride formulation for the treatment of fibromyalgia that is in Phase 1 clinical trials. The company is headquartered in Palo Alto, California. Scilex Holding Company is a subsidiary of Sorrento Therapeutics, Inc.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej